Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B
Autor: | Seung-Hee Jo, Renato G. Panizzon, Paola Ostano, Dania Al Labban, G. Paolo Dotto, Massimo Bongiovanni, Chiara Saglietti |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Keratinocytes Jumonji Domain-Containing Histone Demethylases Notch signaling pathway Mice SCID Biology medicine.disease_cause Proinflammatory cytokine 03 medical and health sciences Mice Mice Inbred NOD Cell Line Tumor medicine Biomarkers Tumor Gene silencing Animals Humans Transcription factor Notch 1 Biomarkers Tumor/genetics Biomarkers Tumor/metabolism Carcinoma Squamous Cell/genetics Carcinoma Squamous Cell/metabolism Carcinoma Squamous Cell/pathology Immunoglobulin J Recombination Signal Sequence-Binding Protein/genetics Immunoglobulin J Recombination Signal Sequence-Binding Protein/metabolism Jumonji Domain-Containing Histone Demethylases/genetics Jumonji Domain-Containing Histone Demethylases/metabolism Keratinocytes/metabolism Keratinocytes/pathology Neoplasm Proteins/genetics Neoplasm Proteins/metabolism Neoplasms Experimental/genetics Neoplasms Experimental/metabolism Neoplasms Experimental/pathology Receptors Notch/genetics Receptors Notch/metabolism Signal Transduction Cell Biology Head & neck cancer Lung cancer Oncology Skin cancer Receptors Notch General Medicine Neoplasms Experimental 3. Good health Neoplasm Proteins stomatognathic diseases 030104 developmental biology Histone Immunoglobulin J Recombination Signal Sequence-Binding Protein Cancer research biology.protein Carcinoma Squamous Cell Signal transduction Carcinogenesis Research Article |
Zdroj: | The Journal of clinical investigation, vol. 128, no. 6, pp. 2581-2599 |
Popis: | Notch 1/2 genes play tumor-suppressing functions in squamous cell carcinoma (SCC), a very common malignancy in skin and internal organs. In contrast with Notch, we show that the transcription factor CSL (also known as RBP-Jκ), a key effector of canonical Notch signaling endowed with intrinsic transcription-repressive functions, plays a tumor-promoting function in SCC development. Expression of this gene decreased in upper epidermal layers and human keratinocytes (HKCs) undergoing differentiation, while it increased in premalignant and malignant SCC lesions from skin, head/neck, and lung. Increased CSL levels enhanced the proliferative potential of HKCs and SCC cells, while silencing of CSL induced growth arrest and apoptosis. In vivo, SCC cells with increased CSL levels gave rise to rapidly expanding tumors, while cells with silenced CSL formed smaller and more differentiated tumors with enhanced inflammatory infiltrate. Global transcriptomic analysis of HKCs and SCC cells with silenced CSL revealed major modulation of apoptotic, cell-cycle, and proinflammatory genes. We also show that the histone demethylase KDM6B is a direct CSL-negative target, with inverse roles of CSL in HKC and SCC proliferative capacity, tumorigenesis, and tumor-associated inflammatory reaction. CSL/KDM6B protein expression could be used as a biomarker of SCC development and indicator of cancer treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |